Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 392
Filter
1.
Emerg Microbes Infect ; 13(1): 2358073, 2024 Dec.
Article in English | MEDLINE | ID: mdl-38764403

ABSTRACT

Mycobacterium chelonae and Sporothrix globosa, both of which are opportunistic pathogens, have been proved to be possible multidrug resistant. However, are all recurring symptoms in chronic infections related to decreasing susceptibility? Here we report a case of sporotrichosis secondary to M. chelonae infection. In addition, we find that the blackish-red spots under the dermoscopic view can be employed as a signal for the early identification and regression of subcutaneous fungal infection.


Subject(s)
Mycobacterium Infections, Nontuberculous , Mycobacterium chelonae , Sporothrix , Sporotrichosis , Sporothrix/isolation & purification , Sporothrix/genetics , Sporothrix/drug effects , Sporotrichosis/microbiology , Humans , Mycobacterium chelonae/isolation & purification , Mycobacterium Infections, Nontuberculous/microbiology , Male , Coinfection/microbiology
3.
Rheumatol Int ; 41(9): 1691-1697, 2021 Sep.
Article in English | MEDLINE | ID: mdl-32888053

ABSTRACT

Mycobacterial infection can be seriously debilitating and challenging to diagnose. The infection can mimic vasculitis associated with positive anti-neutrophilic cytoplasmic autoantibodies (ANCA). This clinical scenario is exemplified with a well-studied case of a 63-year-old Caucasian man with uncontrolled diabetes and ulcerative colitis on immunosuppressive agents. The patient was hospitalized for 3 months with worsening painful hand ulcerations. Primary vasculitis was first suspected, but the patient was later diagnosed with vasculitis secondary to Mycobacterium chelonae infection. Report includes discussion on sequence of testing which led to the diagnosis. After proper diagnosis and change to proper antibiotics, the patient's vasculitis improved over time. It is our hope that this report further raises awareness of mycobacterial infection as a mimicker of vasculitis. We also provide a review of relevant literature on non-tuberculosis mycobacterial (NTM) infection including a review of 22 articles and 12 cases found in the literature. The salient features of the literature review include that 10 of the 12 cases were patients who had risk factors of immunosuppression due to medications, and all patients were infected by mycobacterium causing skin vasculitis. After given the proper directed antibiotic treatment, 11 of the 12 patients had a reported improved outcome.


Subject(s)
Colitis, Ulcerative/drug therapy , Gastrointestinal Agents/adverse effects , Infliximab/adverse effects , Mycobacterium Infections, Nontuberculous/chemically induced , Antibodies, Antineutrophil Cytoplasmic/blood , Diagnosis, Differential , Gastrointestinal Agents/administration & dosage , Humans , Infliximab/administration & dosage , Male , Middle Aged , Mycobacterium chelonae/isolation & purification , Skin Ulcer/chemically induced , Vasculitis
4.
PLoS One ; 15(11): e0236533, 2020.
Article in English | MEDLINE | ID: mdl-33166284

ABSTRACT

Mycobacterium chelonae is a rapidly growing nontuberculous mycobacterium that is a common cause of nosocomial infections. Here we describe investigation of a possible nosocomial transmission of M. chelonae at the Hospital of the University of Pennsylvania (HUP). M. chelonae strains with similar high-level antibiotic resistance patterns were isolated from two patients who developed post-operative infections at HUP in 2017, suggesting a possible point source infection. The isolates, along with other clinical isolates from other patients, were sequenced using the Illumina and Oxford Nanopore technologies. The resulting short and long reads were hybrid assembled into draft genomes. The genomes were compared by quantifying single nucleotide variants in the core genome and assessed using a control dataset to quantify error rates in comparisons of identical genomes. We show that all M. chelonae isolates tested were highly dissimilar, as indicated by high pairwise SNV values, consistent with environmental acquisition and not a nosocomial point source. Our control dataset determined a threshold for evaluating identity between strains while controlling for sequencing error. Finally, antibiotic resistance genes were predicted for our isolates, and several single nucleotide variants were identified that have the potential to modulated drug resistance.


Subject(s)
Cross Infection/diagnosis , DNA, Bacterial/analysis , Genome, Bacterial , Mycobacterium Infections/diagnosis , Mycobacterium chelonae/isolation & purification , Sequence Analysis, DNA/methods , Whole Genome Sequencing/methods , Cross Infection/epidemiology , Cross Infection/microbiology , DNA, Bacterial/genetics , High-Throughput Nucleotide Sequencing , Humans , Mycobacterium Infections/epidemiology , Mycobacterium Infections/microbiology , Mycobacterium chelonae/classification , Mycobacterium chelonae/genetics , Philadelphia/epidemiology , Phylogeny
5.
Rev. esp. quimioter ; 33(4): 249-257, ago. 2020. tab
Article in English | IBECS | ID: ibc-197888

ABSTRACT

OBJECTIVES: Hemophagocytic syndrome (HPS) is characterized by various clinical and biological data derived from cytokine hyperproduction and cell proliferation. The objectives of this study were to evaluate the epidemiological, etiological, clinical and evolutionary characteristics of patients diagnosed with hemophagocytic syndrome and HIV infection, as well as their comparison with data from the literature. METHODS: A retrospective descriptive observational study was performed, including all adult patients with a diagnosis of HPS and HIV infection treated in the Infectious Diseases and Tropical Medicine Unit of the Hospital Universitario Insular, Las Palmas, Gran Canaria from June 1, 1998 to December 31, 2018. RESULTS: An analysis of this series of case reports of 15 patients showed a higher percentage of males than females, with a mean age of 42 years. With respect to the diagnostic criteria for HPS, presence of fever, cytopenias and hyperferritinemia were a constant in all patients. Clinical neurological manifestations were frequent and clinical respiratory signs and symptoms absent. HPS was confirmed in some patients who were not severely immune-depressed and had undetectable viral loads. Furthermore, 40% of cases were not receiving ART. The most frequent triggering causes of HPS were viral, especially HHV-8. In addition, two new HPS triggers were identified: Blastocystis dermatitidis and Mycobacterium chelonae. CONCLUSION: Administration of treatment in HPS is arbitrary. This, together with the high mortality rate and the fact that it is underdiagnosed, indicates the importance of conducting future studies


OBJETIVOS: El síndrome hemofagocítico (HPS) se caracteriza por varios datos clínicos y biológicos derivados de la hiperproducción de citocinas y proliferación celular. Los objetivos fueron evaluar las características epidemiológicas, etiológicas, clínicas y evolutivas de los pacientes con diagnóstico de síndrome hemofagocítico e infección por VIH así como su comparación con los datos bibliográficos. PACIENTES Y MÉTODOS: Se realizó un estudio observacional descriptivo retrospectivo incluyendo todos los pacientes adultos con diagnóstico de HPS e infección por VIH, atendidos en la Unidad de Enfermedades Infecciosas y Medicina Tropical del Hospital Universitario Insular de Las Palmas de Gran Canaria desde 1 de junio 1998 hasta 31 de diciembre de 2018. RESULTADOS: Se analizó una serie de casos de 15 pacientes, observando un mayor porcentaje de varones con edad media de 42 años. En cuanto a los criterios de HPS se observa que la presencia de fiebre, citopenias e hiperferritinemia era constante en todos los pacientes. Las manifestaciones clínicas neurológicas fueron frecuentes y ausente la clínica respiratoria. Se confirmó HPS en algunos pacientes sin inmunodepresión grave y carga viral indetectable. Además, un 40% de los casos no recibían ART. Las causas desencadenantes de HPS más frecuentes fueron las víricas, especialmente HHV-8. Además, se identificaron dos nuevos agentes desencadenantes de HPS: Blastocystis dermatitidis y Mycobacterium chelonae. CONCLUSIÓN: La administración de tratamiento en HPS es arbitraria lo que unido a su alta tasa de mortalidad e infradiagnóstico indican la importancia de continuar realizando estudios futuros


Subject(s)
Humans , Male , Female , Adult , Middle Aged , HIV Infections/complications , Lymphohistiocytosis, Hemophagocytic/complications , Mycobacterium chelonae/isolation & purification , Blastocystis/isolation & purification , Retrospective Studies , Iron Overload/etiology , Blastocystis Infections/epidemiology , Mycobacterium Infections, Nontuberculous/epidemiology
6.
J Infect Chemother ; 26(8): 843-846, 2020 Aug.
Article in English | MEDLINE | ID: mdl-32402735

ABSTRACT

Mycobacterium chelonae is a rapidly growing mycobacterium that has the potential to cause refractory infections in humans. Mycobacteremia resulting from the organism is extremely rare, and its clinical features are yet to be uncovered. We herein present a case of M. chelonae bloodstream infection involving an immunocompromised older patient. A 79-year-old woman, on a long-term treatment with prednisolone plus tacrolimus for rheumatoid arthritis, visited our outpatient department complaining of deteriorating pain and swelling at her right 1st toe. Laboratory parameters showed elevated C-reactive protein and leukocytosis, and magnetic resonance imaging indicated osteomyelitis at the proximal phalanx of her right 1st toe. Considering the refractory course, the infected toe was immediately amputated. M. chelonae was isolated from bacterial cultures of the resected tissue and blood (BD BACTEC™ FX blood culture system, Becton Dickinson, Sparks, MD, USA), leading to a diagnosis of disseminated M. chelonae infection. We treated the patient with an antibiotic combination of clarithromycin, minocycline, and imipenem (2 weeks), which was converted to oral therapy of clarithromycin, doxycycline, and levofloxacin. This case highlighted the potential pathogenesis of M. chelonae to cause mycobacteremia in an immunocompromised patient.


Subject(s)
Bacteremia/diagnosis , Mycobacterium Infections, Nontuberculous/diagnosis , Mycobacterium chelonae/isolation & purification , Osteomyelitis/diagnosis , Toes/pathology , Aged , Anti-Bacterial Agents/therapeutic use , Bacteremia/drug therapy , Bacteremia/etiology , Drug Therapy, Combination , Female , Humans , Immunocompromised Host , Magnetic Resonance Imaging , Mycobacterium Infections, Nontuberculous/drug therapy , Mycobacterium Infections, Nontuberculous/etiology , Osteomyelitis/complications , Osteomyelitis/drug therapy , Osteomyelitis/microbiology , Toes/diagnostic imaging , Treatment Outcome
7.
Spine (Phila Pa 1976) ; 45(9): E525-E532, 2020 May 01.
Article in English | MEDLINE | ID: mdl-32282655

ABSTRACT

MINI: We compared the sensitivity and specificity of peri-implant tissue culture to the vortexing-sonication technique for the diagnosis of spinal implant infection (SII). Lower thresholds of sonicate fluid culture positivity showed increased sensitivity with maintained specificity. We recommend a threshold of 20 CFU/10 mL for sonicate culture positivity for the diagnosis of SII. STUDY DESIGN: This is a retrospective study comparing the diagnosis of spinal implant infection (SII) by peri-implant tissue culture to vortexing-sonication of retrieved spinal implants. OBJECTIVE: We hypothesized that vortexing-sonication would be more sensitive than peri-implant tissue culture. SUMMARY OF BACKGROUND DATA: We previously showed implant vortexing-sonication followed by culture to be more sensitive than standard peri-implant tissue culture for diagnosing of SII. In this follow-up study, we analyzed the largest sample size available in the literature to compare these two culture methods and evaluated thresholds for positivity for sonicate fluid for SII diagnosis. METHODS: We compared peri-implant tissue culture to the vortexing-sonication technique which samples bacterial biofilm on the surface of retrieved spinal implants. We evaluated different thresholds for sonicate fluid positivity and assessed the sensitivity and specificity of the two culture methods for the diagnosis of SII. RESULTS: A total of 152 patients were studied. With more than 100 colony forming units (CFU)/10 mL as a threshold for sonicate fluid culture positivity, there were 46 patients with SII. The sensitivities of peri-implant tissue and sonicate fluid culture were 65.2% and 79.6%; the specificities were 88.7% and 93.4%, respectively. With more than 50 CFU/10 mL as a threshold, there were 50 patients with SII. The sensitivities of peri-implant tissue and sonicate fluid culture were 68.0% and 76.0%; the specificities were 92.2% for both methods. Finally, with more than or equal to 20 CFU/10 mL as a threshold, there were 52 patients with SII. The sensitivities of peri-implant tissue and sonicate fluid culture were 69.2% and 82.7%; the specificities were 94.0% and 92.0%, respectively. CONCLUSION: Implant sonication followed by culture is a sensitive and specific method for the diagnosis of SII. Lower thresholds for defining sonicate fluid culture positivity allow for increased sensitivity with a minimal decrease in specificity, enhancing the clinical utility of implant sonication. LEVEL OF EVIDENCE: 4.


This is a retrospective study comparing the diagnosis of spinal implant infection (SII) by peri-implant tissue culture to vortexing­sonication of retrieved spinal implants. We hypothesized that vortexing­sonication would be more sensitive than peri-implant tissue culture. We previously showed implant vortexing­sonication followed by culture to be more sensitive than standard peri-implant tissue culture for diagnosing of SII. In this follow-up study, we analyzed the largest sample size available in the literature to compare these two culture methods and evaluated thresholds for positivity for sonicate fluid for SII diagnosis. We compared peri-implant tissue culture to the vortexing­sonication technique which samples bacterial biofilm on the surface of retrieved spinal implants. We evaluated different thresholds for sonicate fluid positivity and assessed the sensitivity and specificity of the two culture methods for the diagnosis of SII. A total of 152 patients were studied. With more than 100 colony forming units (CFU)/10 mL as a threshold for sonicate fluid culture positivity, there were 46 patients with SII. The sensitivities of peri-implant tissue and sonicate fluid culture were 65.2% and 79.6%; the specificities were 88.7% and 93.4%, respectively. With more than 50 CFU/10 mL as a threshold, there were 50 patients with SII. The sensitivities of peri-implant tissue and sonicate fluid culture were 68.0% and 76.0%; the specificities were 92.2% for both methods. Finally, with more than or equal to 20 CFU/10 mL as a threshold, there were 52 patients with SII. The sensitivities of peri-implant tissue and sonicate fluid culture were 69.2% and 82.7%; the specificities were 94.0% and 92.0%, respectively. Implant sonication followed by culture is a sensitive and specific method for the diagnosis of SII. Lower thresholds for defining sonicate fluid culture positivity allow for increased sensitivity with a minimal decrease in specificity, enhancing the clinical utility of implant sonication. Level of Evidence: 4.


Subject(s)
Biofilms/growth & development , Prostheses and Implants/microbiology , Prostheses and Implants/standards , Prosthesis-Related Infections/diagnosis , Sonication/standards , Tissue Culture Techniques/standards , Adolescent , Adult , Aged , Aged, 80 and over , Enterobacter cloacae/isolation & purification , Enterobacter cloacae/physiology , Female , Follow-Up Studies , Humans , Male , Middle Aged , Mycobacterium chelonae/isolation & purification , Mycobacterium chelonae/physiology , Retrospective Studies , Sonication/methods , Tissue Culture Techniques/methods , Young Adult
8.
J Foot Ankle Surg ; 59(2): 413-417, 2020.
Article in English | MEDLINE | ID: mdl-32131013

ABSTRACT

Mycobacterium chelonae is a ubiquitous Gram-positive, acid-fast, non-spore-forming bacterium commonly encountered in nature associated with aquatic animals, soil, and water, including tap water. Nontuberculous mycobacterial tenosynovitis infections caused by M. chelonae in the lower extremity are uncommon, leading to a paucity of literature documenting the diagnosis and treatment of such cases. This report is of a 65-year-old male patient who was found to have an M. chelonae infection along the tibialis anterior tendon after injecting himself with heroin into the dorsal foot veins. This review covers the diagnosis and treatment as well as a case report on the outcome of infectious tenosynovitis of the tibialis anterior associated with M. chelonae. To date, this is the only reported case of tibialis anterior infectious tenosynovitis caused by M. chelonae after intravenous heroin injection.


Subject(s)
Heroin/adverse effects , Mycobacterium Infections, Nontuberculous/etiology , Mycobacterium chelonae/isolation & purification , Narcotic-Related Disorders/complications , Tenosynovitis/etiology , Aged , Heroin/administration & dosage , Humans , Injections, Intravenous , Male , Mycobacterium Infections, Nontuberculous/diagnosis , Mycobacterium Infections, Nontuberculous/microbiology , Tenosynovitis/diagnosis , Tenosynovitis/microbiology , Tibia
11.
Orbit ; 39(6): 415-417, 2020 Dec.
Article in English | MEDLINE | ID: mdl-31858873

ABSTRACT

A 35-year-old woman complained of an unpleasant odor for a few days after a change in foundation cream. The patient had previously undergone conjunctivo-dacryocystorhinostomy with a Jones tube fixed with non-absorbable suture. Slit-lamp examination revealed an orange-colored discharge in the tube. A culture test of the discharge showed Corynebacterium kroppenstedtii (1+), Aspergillus versicolor (1+), and Mycobacterium chelonae (1+). After medical treatment and suture removal, the discharge completely disappeared. This is the first reported case of a Jones tube infection following conjunctivo-dacryocystorhinostomy with multiple microorganisms, including C. kroppenstedtii.


Subject(s)
Aspergillosis/microbiology , Coinfection/microbiology , Conjunctiva/surgery , Corynebacterium Infections/microbiology , Dacryocystorhinostomy , Mycobacterium Infections, Nontuberculous/microbiology , Prostheses and Implants/microbiology , Administration, Ophthalmic , Administration, Oral , Adult , Aspergillosis/diagnosis , Aspergillosis/drug therapy , Aspergillus/isolation & purification , Ciprofloxacin/therapeutic use , Coinfection/diagnosis , Coinfection/drug therapy , Corynebacterium/isolation & purification , Corynebacterium Infections/diagnosis , Corynebacterium Infections/drug therapy , Drug Therapy, Combination , Female , Humans , Intubation/instrumentation , Lacrimal Duct Obstruction/therapy , Levofloxacin/therapeutic use , Mycobacterium Infections, Nontuberculous/diagnosis , Mycobacterium Infections, Nontuberculous/drug therapy , Mycobacterium chelonae/isolation & purification , Ophthalmic Solutions , Retrospective Studies , Slit Lamp Microscopy , Voriconazole/therapeutic use
13.
Rev. esp. quimioter ; 32(5): 451-457, oct. 2019. tab, graf
Article in English | IBECS | ID: ibc-188712

ABSTRACT

INTRODUCTION: Non-pigmented rapidly growing mycobacteria (NPRGM) are a group of organisms of increasing interest due to the growing number of potential patients and the difficulties for a proper treatment in many of them. However, the evolution of these diseases in a long period of time and its evolutionary changes has been described only in a scanty number of reports. MATERIAL AND METHODS: We performed a retrospective study between January 1st 2004 and December 31st 2017 in order to evaluate the clinical significance and types of diseases caused by NPRGM. Patients with isolates of NPRGM during this period were selected for the study, and clinical charts were reviewed using a predefined protocol. RESULTS: During this period we identified 59 patients (76 clinical samples) with isolates of NPRGM, with 12 cases of clinical disease and one patient with doubtful significance (including 6 respiratory tract infections, 2 catheter infections, 1 skin and soft tissue infection, 1 disseminated infection, 1 conjunctivitis, 1 prosthetic joint infection and 1 mastitis). Fifty percent of M. chelonae isolates, 37.5% of M. abscessus isolates and 23.33% of M. fortuitum isolates were clinically significant. None of the isolates of other species were significant. CONCLUSIONS: Most isolates in respiratory samples were contaminants/colonizations. M. abscessus was the main etiological agent in respiratory syndromes, whereas M. chelonae and M. fortuitum were more frequently associated with other infections, especially clinical devices and skin and soft tissue infections


INTRODUCCIÓN: Las micobacterias no pigmentadas de crecimiento rápido (MNPCR) son un grupo de organismos de interés creciente debido al número cada vez mayor de pacientes potenciales y a las dificultades en el tratamiento. Sin embargo, el número de estudios que analizan la evolución de estos casos a lo largo de un periodo de tiempo largo es escaso. MATERIAL Y MÉTODOS: Se realizó un estudio retrospectivo entre el 1 de enero de 2004 y el 31 de diciembre de 2017 para evaluar el significado clínico y los tipos de enfermedades causados por MNPCR. Se seleccionaron para ello aquellos pacientes con aislamientos de MNPCR, y se revisaron las historias clínicas mediante un protocolo predefinido. RESULTADOS: Se identificaron 59 pacientes (76 muestras) con aislamientos de MNPCR, de los cuales 12 presentaron enfermedad y uno tuvo un significado dudoso (incluyendo 6 infecciones respiratorias, 2 infecciones asociadas a catéter, 1 infección de piel y partes blandas, 1 infección diseminada, 1 conjuntivitis, 1 infección de prótesis osteoarticular y 1 mastitis). El 50 % de los aislamientos de Mycobacterium chelonae, el 37,5 % de Mycobacterium abscessus y el 23,33 % de Mycobacterium fortuitum fueron clínicamente significativos. Ninguno de los aislamientos de otras especies fue significativo. CONCLUSIONES: La mayoría de los aislamientos de muestras respiratorias resultaron ser contaminantes/colonizaciones. M. abscessus fue el principal agente etiológico en las infecciones respiratorias, mientras que M. chelonae y M. fortuitum fueron asociados con mayor frecuencia a otras infecciones, especialmente infecciones de piel y partes blandas e infecciones asociadas a dispositivos biomédicos


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Aged, 80 and over , Mycobacterium Infections, Nontuberculous/microbiology , Nontuberculous Mycobacteria/isolation & purification , Mycobacterium Infections, Nontuberculous/epidemiology , Mycobacterium abscessus/isolation & purification , Mycobacterium chelonae/isolation & purification , Mycobacterium fortuitum/isolation & purification , Retrospective Studies , Time Factors
14.
Rev Esp Quimioter ; 32(5): 451-457, 2019 Oct.
Article in English | MEDLINE | ID: mdl-31535542

ABSTRACT

OBJECTIVE: Non-pigmented rapidly growing mycobacteria (NPRGM) are a group of organisms of increasing interest due to the growing number of potential patients and the difficulties for a proper treatment in many of them. However, the evolution of these diseases in a long period of time and its evolutionary changes has been described only in a scanty number of reports. METHODS: We performed a retrospective study between January 1st 2004 and December 31st 2017 in order to evaluate the clinical significance and types of diseases caused by NPRGM. Patients with isolates of NPRGM during this period were selected for the study, and clinical charts were reviewed using a predefined protocol. RESULTS: During this period we identified 59 patients (76 clinical samples) with isolates of NPRGM, with 12 cases of clinical disease and one patient with doubtful significance (including 6 respiratory tract infections, 2 catheter infections, 1 skin and soft tissue infection, 1 disseminated infection, 1 conjunctivitis, 1 prosthetic joint infection and 1 mastitis). Fifty percent of M. chelonae isolates, 37.5% of M. abscessus isolates and 23.33% of M. fortuitum isolates were clinically significant. None of the isolates of other species were significant. CONCLUSIONS: Most isolates in respiratory samples were contaminants/colonizations. M. abscessus was the main etiological agent in respiratory syndromes, whereas M. chelonae and M. fortuitum were more frequently associated with other infections, especially clinical devices and skin and soft tissue infections.


Subject(s)
Mycobacterium Infections, Nontuberculous/microbiology , Nontuberculous Mycobacteria/isolation & purification , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Mycobacterium Infections, Nontuberculous/epidemiology , Mycobacterium abscessus/isolation & purification , Mycobacterium chelonae/isolation & purification , Mycobacterium fortuitum/isolation & purification , Retrospective Studies , Spain , Time Factors
15.
Int J Mycobacteriol ; 8(2): 157-161, 2019.
Article in English | MEDLINE | ID: mdl-31210158

ABSTRACT

Background: Nontuberculous mycobacteria (NTM) have been identified in human pulmonary and extrapulmonary infections and are increasing globally, which makes it challenging to identify them. This article reports our experience with the laboratory identification of NTM in clinical practice among pulmonary and extrapulmonary samples received in our routine work. Methods: The study was conducted at the Université Catholique de Louvain at the Cliniques Universitaires Saint-Luc, Brussels, Belgium, from 2015 to 2018. A total of 386 clinical samples were collected from patients suspected of having pulmonary or extrapulmonary mycobacterial infections. Routine laboratory methods phenotypic and molecular tests were performed. Results: The majority of NTM species were isolated from pulmonary samples (68%). The most prevalent species identified were Mycobacterium chimaera_intracellulare group (32%), followed by Mycobacterium avium complex (21%), Mycobacterium abscessus complex (18%), Mycobacterium gordonae (9%), and Mycobacterium chelonae (4%). In extrapulmonary samples, M. avium and M. chimaera_intracellulare were the most frequently isolated. Conclusion: The species diversity of NTM found in our setting suggests the importance of the use of new modern methods for accurate identification of NTM at species level and in some case at subspecies level for the proper treatment and management of patients.


Subject(s)
Mycobacterium Infections, Nontuberculous/diagnosis , Nontuberculous Mycobacteria/isolation & purification , Belgium , Clinical Laboratory Techniques , High-Throughput Nucleotide Sequencing , Humans , Laboratories, Hospital , Lung/microbiology , Mycobacterium Infections, Nontuberculous/microbiology , Mycobacterium avium Complex/isolation & purification , Mycobacterium chelonae/isolation & purification , Retrospective Studies , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Sputum/microbiology
16.
Acta Derm Venereol ; 99(10): 889-893, 2019 Sep 01.
Article in English | MEDLINE | ID: mdl-31141157

ABSTRACT

Mycobacterium chelonae is a rapidly growing non-tuberculous mycobacterium, which causes infections of the human skin and soft tissue. Despite an increasing incidence of such infections, patients are often misdiagnosed. We report here 5 patients with cutaneous and/or soft tissue infection due to M. chelonae who were diagnosed and treated at our centre. Two of the 5 patients were on immunosuppressive treatment. While clinical presentations differed in each patient, all had a long history of skin lesions. In addition to careful history-taking, tissue biopsies were obtained for mycobacterial culture and histopathological examination. Culture-directed antibiotic therapy was initiated, which resulted in a slow, but continuous, healing of the lesions. In summary, M. chelonae infections are still relatively rare, but should be considered in both immunocompromised and immunocompetent patients with prolonged skin lesions resistant to standard antibiotic treatment. For diagnosis, tissue analysis for mycobacterial culture and histopathological examination, and once diagnosed, adequate antibiotic treatment, is needed.


Subject(s)
Mycobacterium Infections, Nontuberculous/microbiology , Mycobacterium chelonae/isolation & purification , Opportunistic Infections/microbiology , Skin Diseases, Bacterial/microbiology , Soft Tissue Infections/microbiology , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/therapeutic use , Female , Humans , Immunocompromised Host , Immunosuppressive Agents/adverse effects , Male , Microbial Sensitivity Tests , Mycobacterium Infections, Nontuberculous/diagnosis , Mycobacterium Infections, Nontuberculous/drug therapy , Mycobacterium Infections, Nontuberculous/immunology , Mycobacterium chelonae/drug effects , Opportunistic Infections/diagnosis , Opportunistic Infections/drug therapy , Opportunistic Infections/immunology , Skin Diseases, Bacterial/diagnosis , Skin Diseases, Bacterial/drug therapy , Skin Diseases, Bacterial/immunology , Soft Tissue Infections/diagnosis , Soft Tissue Infections/drug therapy , Soft Tissue Infections/immunology , Treatment Outcome
18.
Cornea ; 38(5): 632-634, 2019 May.
Article in English | MEDLINE | ID: mdl-30747739

ABSTRACT

PURPOSE: To describe the first reported case of Mycobacterium chelonae-related interface keratitis after Descemet membrane endothelial keratoplasty (DMEK), successfully treated with DMEK exchange. METHODS: A case of donor-related DMEK interface keratitis, treated with medical therapy and DMEK exchange, was studied retrospectively. RESULTS: A patient with Fuchs endothelial dystrophy developed infectious interface keratitis after DMEK. In cultures of the donor cornea transport medium, M. chelonae was isolated. Subsequent clinical investigation showed early signs of infectious keratitis with multiple infiltrates at the donor-graft interface. Cultures at the cornea bank of origin also showed M. chelonae, indicating a donor-related infection. Because of unsuccessful medical therapy, the DMEK graft was exchanged 4.5 months after initial DMEK. After 2 weeks, some interface precipitates appeared. These precipitates regressed over the following months with continued medical therapy. Antibiotic therapy was successfully ended 5 months after DMEK exchange. CONCLUSION: This case highlights the importance of early diagnosis and intensive treatment of nontuberculous mycobacterial interface keratitis. If intensive medical therapy is able to contain infection but fails to eradicate interface keratitis, DMEK exchange is a possible treatment option.


Subject(s)
Descemet Stripping Endothelial Keratoplasty/adverse effects , Eye Infections, Bacterial/microbiology , Fuchs' Endothelial Dystrophy/surgery , Keratitis/microbiology , Mycobacterium Infections, Nontuberculous/microbiology , Mycobacterium chelonae/isolation & purification , Tissue Donors , Aged , Humans , Male , Postoperative Complications/microbiology , Retrospective Studies
19.
J Pediatric Infect Dis Soc ; 8(4): 291-296, 2019 Sep 25.
Article in English | MEDLINE | ID: mdl-29850835

ABSTRACT

BACKGROUND: Mycobacterium abscessus, an emerging pathogen in healthcare settings, has rarely been associated with community outbreaks. During February-May 2013, Idaho public health officials and pediatric infectious disease physicians investigated an outbreak of M abscessus skin infections in children whose only common exposure was an indoor wading pool. METHODS: Healthcare providers and parents reported possible M abscessus cases. We used a standardized questionnaire to interview parents of affected children. Clinical specimens were submitted for mycobacterial examination. We conducted an environmental investigation of the pool. Microbial isolates from clinical and environmental samples were identified by sequencing polymerase chain reaction amplicons and underwent pulsed-field gel electrophoresis. RESULTS: Twelve cases were identified. Specimens from 4 of 7 children grew M abscessus or Mycobacterium abscessus/Mycobacterium chelonae . Ten (83%) of 12 children were female; median age was 3 years (range, 2 to 6 years); and all were immunocompetent. Pool maintenance did not fully comply with Idaho state rules governing pool operation. Mycobacterium abscessus/chelonae was isolated from pool equipment. Pulsed-field gel electrophoresis composite patterns were 87% similar between isolates from the pool ladder and 1 patient, and they were 90% similar between isolates from 2 patients. Environmental remediation included hyperchlorination, scrubbing and disinfection of pool surfaces, draining the pool, and replacement of worn pool materials. CONCLUSIONS: Immunocompetent children acquired M abscessus cutaneous infection involving hands and feet after exposure to a wading pool. Environmental remediation and proper pool maintenance likely halted transmission. Medical and public health professionals' collaboration effectively detected and controlled an outbreak caused by an emerging recreational waterborne pathogen.


Subject(s)
Disease Outbreaks , Mycobacterium Infections, Nontuberculous/epidemiology , Mycobacterium Infections, Nontuberculous/microbiology , Mycobacterium abscessus/isolation & purification , Child , Child, Preschool , Female , Foot Diseases/microbiology , Hand , Humans , Idaho/epidemiology , Male , Mycobacterium abscessus/genetics , Mycobacterium chelonae/genetics , Mycobacterium chelonae/isolation & purification , Surveys and Questionnaires , Swimming Pools
SELECTION OF CITATIONS
SEARCH DETAIL
...